ROISIN E OCEARBHAILL

Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology NEW YORK, NY NPI 1821241043

General Payments — all program years on this page

$45,790.35

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 44
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $7,774.67 across 10 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Regeneron Pharmaceuticals, Inc. $3,775.863
ABBVIE INC. $2,329.773
PFIZER INC. $1,575.992
GlaxoSmithKline, LLC. $93.052

By program year

Program yearAmountRecords
2018 $4,405.3212
2019 $215.113
2020 $3,575.002
2021 $14,357.505
2022 $5,685.003
2023 $9,777.759
2024 $7,774.6710

Records — PY2024 (10)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1105139282 ABBVIE INC. $82.72 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105139284 ABBVIE INC. $2,100.00 04/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105139286 ABBVIE INC. $147.05 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114403053 Regeneron Pharmaceuticals, Inc. $99.36 06/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114403055 Regeneron Pharmaceuticals, Inc. $817.00 08/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114403057 Regeneron Pharmaceuticals, Inc. $2,859.50 08/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1116434526 GlaxoSmithKline, LLC. $59.55 03/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116472571 GlaxoSmithKline, LLC. $33.50 03/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131359789 PFIZER INC. $1,380.00 07/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1131587070 PFIZER INC. $195.99 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.